Journal
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
Volume 6, Issue 6, Pages 597-599Publisher
INFORMA HEALTHCARE
DOI: 10.1586/17512433.2013.841078
Keywords
chronic liver disease; fibrosis; hepatic stellate cells; nuclear hormone receptor; vitamin D
Categories
Funding
- Howard Hughes Medical Institute Funding Source: Medline
- NCI NIH HHS [P30 CA014195, CA014195] Funding Source: Medline
- NHLBI NIH HHS [P01 HL088093, R01 HL105278, HL088093, HL105278] Funding Source: Medline
- NIDDK NIH HHS [DK057978, R24 DK090962, R37 DK057978, DK090962] Funding Source: Medline
- NIEHS NIH HHS [ES010337, P42 ES010337] Funding Source: Medline
Ask authors/readers for more resources
...both benchside and bedside studies could move vitamin D receptor- targeted therapies to the center stage of hepatology and pave the way for the development of a new pipeline of vitamin D receptor ligands with therapeutic promise for a wide range of liver disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
